Assessment of Serum Interleukin-15 in Alopecia Areata patients | ||
| International Journal of Medical Arts | ||
| Article 11, Volume 7, Issue 5, May 2025, Pages 5726-5731 PDF (1.74 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ijma.2024.284207.1958 | ||
| Authors | ||
| Aya Taha Abd Elfattah Mohamed* 1; Rabie Bedir Atallah2; Mohamed Shokry Zaky2; Sherif Ibrahim ElGhannam3 | ||
| 1Department of Dermatology and Venereology, Mansoura Dermatology and Leprosy Hospital, Ministry of Health, Mansoura, Egypt | ||
| 2Department of Dermatology, Venerology and Andrology, Damietta Faculty of Medicine, Al-Azhar University; Damietta, Egypt | ||
| 3Department of Clinical Pathology, Damietta Faculty of Medicine, Al-Azhar University; Damietta, Egypt | ||
| Abstract | ||
| Background: Alopecia Areata [AA] is the commonest cause of non-scaring alopecia. Its incidence reached up to 3.8%. it is considered as an autoimmune disease. However, its onset, course and response to treatment are not predictable. Interleukin-15 [IL-15] seems to play a crucial pathogenetic role. However, the evidence is not conclusive. The current work aimed to measure the IL-15 values in AA, comparing it to healthy volunteers and investigates its potential association with disease activity and severity and its diagnostic role. Patients and Methods: This is a case-control comparative study, which included 80 subjects [40 with AA and 40 age and sex-matched apparently healthy controls]. All were clinically evaluated and serum levels of IL-15 were measured and correlated with disease severity [determined by Severity of Alopecia Tool [SALT]]. Dermoscopy was performed to confirm the diagnosis. Results: Both study and controls were comparable regarding patient demographics. However, 52.5% of the cases had active disease, and 20% had severe disease. There was a significant increase of IL-15 in the cases than the control group [median values were 542.66 vs 264.54, respectively] However, there was insignificant link between serum IL-15 and each of patient age, sex and marital status. But there was a significant higher value of IL-15 among cases with severe than active and or stable disease [646.8, than 537.5 or 456.76, respectively]. IL-15 is a good test for diagnosis of AA. The area under curve [AUC] was excellent [0.944]. The best recorded cut off point was 368.06 with sensitivity of 97.5%, specificity 85% and total accuracy 91.3%. Conclusion: IL-15 could be considered as a valid and reliable indicator for disease development and progress. It also can be used as a follow up marker for treatment. | ||
| Keywords | ||
| Cytokines; Hair loss; Alopecia; Interleukins; Autoimmune | ||
|
Statistics Article View: 143 PDF Download: 47 |
||
